Traws Pharma, Inc.TRAWNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+63.8%
5Y CAGR+312.2%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+63.8%/yr
vs -51.0%/yr prior
5Y CAGR
+312.2%/yr
Recent deceleration
Acceleration
+114.8pp
Accelerating
Percentile
P96
Near historical high
vs 5Y Ago
1189.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q2 2025 | 4694.74% |
| Q4 2024 | 1.79% |
| Q2 2024 | -50.44% |
| Q4 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q2 2021 | -8.13% |
| Q4 2020 | 13.89% |
| Q2 2020 | 16.13% |
| Q4 2019 | -95.55% |
| Q2 2019 | 1067.60% |
| Q4 2018 | -82.94% |
| Q2 2018 | 314.62% |
| Q4 2017 | -52.62% |
| Q2 2017 | -70.72% |
| Q4 2016 | -50.99% |
| Q2 2016 | -66.82% |
| Q4 2015 | 4633.76% |
| Q2 2015 | 3.95% |
| Q4 2014 | -60.14% |
| Q2 2014 | -81.22% |
| Q4 2013 | 78.44% |
| Q2 2013 | -96.27% |
| Q4 2012 | 10850.24% |
| Q2 2012 | 0.00% |